No abstract available
MeSH terms
-
Allopurinol / therapeutic use
-
Antimetabolites / therapeutic use
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Cost-Benefit Analysis
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Neoplasms / drug therapy*
-
Risk Factors
-
Tumor Lysis Syndrome / economics
-
Tumor Lysis Syndrome / etiology*
-
Tumor Lysis Syndrome / prevention & control
-
Urate Oxidase / economics
-
Urate Oxidase / therapeutic use
-
Uric Acid / metabolism
-
Water-Electrolyte Balance
Substances
-
Antimetabolites
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
rasburicase
-
Uric Acid
-
Allopurinol
-
Urate Oxidase